Treatment of Postvitrectomy Fibrin Formation With Intraocular Tissue Plasminogen Activator
- 1 August 1988
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 106 (8) , 1055-1058
- https://doi.org/10.1001/archopht.1988.01060140211025
Abstract
• Twenty-five micrograms of human recombinant tissue plasminogen activator (tPA) was injected intracamerally into the eyes of three aphakic patients who developed severe intraocular fibrin formation within 24 hours after vitrectomy surgery. Fluid obtained from gas-fluid exchange specimens taken 24 hours after tPA injection was analyzed for tPA by an enzymelinked immunosorbent assay and a spectrophotometric solid-phase fibrin assay. In each of the three patients, complete fibrin resolution occurred within four hours after the tPA injection. There were no complications associated with the intraocular tPA injections. There was measurable tPA activity 24 hours after the initial injection ranging from 0.23 to 1.4 μg. In contrast, tPA was undetectable in gas-fluid exchange specimens obtained from seven patients who did not receive intraocular tPA injections. Intraocular tPA is an effective means of treating postvitrectomy fibrin formation in selected aphakic patients.This publication has 9 references indexed in Scilit:
- Treatment of Experimental Intravitreal Fibrin with Tissue Plasminogen ActivatorAmerican Journal of Ophthalmology, 1987
- Intraocular Fibrinolysis With Recombinant Human Tissue Plasminogen ActivatorArchives of Ophthalmology (1950), 1987
- Changing Indications and Techniques for Vitrectomy in Management of Complications of Diabetic RetinopathyOphthalmology, 1987
- Use of Tissue Plasminogen Activator in Experimental HyphemaArchives of Ophthalmology (1950), 1987
- Management of Fibrin Pupillary-Block Glaucoma After Pars Plana Vitrectomy With Intravitreal Gas InjectionAmerican Journal of Ophthalmology, 1987
- Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial.Circulation, 1986
- Fibrin: Mediator ofin vivoandin vitroinjury and inflammationCurrent Eye Research, 1985
- Effect of Fibrin on Morphologic Characteristics of Retinal Pigment Epithelial CellsArchives of Ophthalmology (1950), 1984
- Acquired deficiency and urinary excretion of antithrombin III in nephrotic syndromeArchives of internal medicine (1960), 1984